Oceania Healthcare (OCA) Fundamentals 2026 — P/E 7700.0x, Revenue Analysis | SniperIQ
Oceania Healthcare (OCA) is a NZ-listed Healthcare company in Medical - Care Facilities with a market capitalization of A$442M, trading at A$0.61 on the ASX. This SniperIQ fundamentals page covers Oceania Healthcare's valuation (P/E 7700.0x, P/B 0.5x), profitability (net margin 0.0%), revenue (NZD 269M in FY2026), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Oceania Healthcare's market cap?
Oceania Healthcare (OCA) has a market capitalization of approximately A$442M, trading at A$0.61 on the ASX. Market cap moves with the live share price.
What is Oceania Healthcare's P/E ratio?
Oceania Healthcare's trailing twelve-month P/E ratio is 7700.0x, with a price-to-book (P/B) of 0.5x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Oceania Healthcare?
Oceania Healthcare runs a net profit margin of 0.0%, a gross margin of -8.4%, and an operating margin of -10.1%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Oceania Healthcare generate?
Oceania Healthcare reported revenue of NZD 269M for fiscal year 2026, with net income of NZD 119,000 and earnings per share (EPS) of 0.0002. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Oceania Healthcare pay a dividend?
Oceania Healthcare does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is Oceania Healthcare financially healthy?
Oceania Healthcare carries a debt-to-equity ratio of 0.45x and a current ratio of 0.12x, with a market beta of 0.61. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Oceania Healthcare a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Oceania Healthcare (OCA) the key facts are: market cap A$442M, P/E 7700.0x, revenue NZD 269M, 52-week range 0.52-0.82. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Oceania Healthcare's full fundamentals live
Get Oceania Healthcare's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.